News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search Vall d'Hebron participates in a guide for clinical trials with drug combinations 04/05/2023 New marker enables discontinuation of unnecessary aspirin medicalization during pregnancy 29/03/2023 Vall d’Hebron inclou el primer pacient en un estudi pioner en teràpia CAR-T per al lupus 23/03/2023 clinical trial to evaluate the benefits of physical exercise in elderly people with cancer 01/03/2023 Vall d'Hebron will develop medicines for children with a 3D printer 31/01/2023 Results of the RACECAT study quoted in the prestigious journal JAMA 05/05/2022 Hepatology is the Service with the highest participation in liver disease trials 22/02/2022 A phase I clinical trial with Vall d'Hebron participation shows good results of a drug against childhood cancer 21/01/2022 Patients with stroke and COVID-19 have more severe strokes and higher mortality 20/12/2021 Vall d’Hebron identifies a new strategy which will help understand the causes of strokes 19/11/2021 Vall d'Hebron publishes the first results of a study to implement a rapid stroke treatment pathway 22/08/2021 Vall d'Hebron leads a multicenter study that will assess a faster workflow for the management of patients with stroke 07/07/2021 Vall d’Hebron has reached a record number of clinical trials despite the pandemic 19/05/2021 Three professionals from Vall d'Hebron, winners of the Spanish Society of Neurology Awards 25/03/2021 A study by Vall d’Hebron shows that patients with severe pulmonary injury due to COVID-19 have increased risk of stroke 26/08/2020 The combination of ticagrelor and aspirin reduces the risk of recurrence and disability in patients with stroke 28/07/2020 Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company 23/04/2018 Pagination « First First page ‹ Previous Previous page 1 2